Subcutaneous Fat vs. Visceral Fat: What’s the Difference and Which Carries More Health Risk?

Body fat is not one uniform tissue stored in one place. Two people with a similar amount of total body fat can have very different patterns of fat distribution—and those patterns can matter for health.

Subcutaneous fat sits beneath the skin. It makes up much of the fat you can pinch around the abdomen, hips, thighs, arms, and other parts of the body. Visceral fat is stored deeper inside the abdominal cavity around internal organs. Both are forms of adipose tissue, but they differ in location, biology, and their associations with disease risk.

At a population level, excess visceral fat is more strongly associated with insulin resistance, type 2 diabetes, abnormal blood lipids, hypertension, fatty liver disease, and cardiovascular disease than subcutaneous fat. That does not make all subcutaneous fat harmless or visceral fat the only feature that matters. Total adiposity, fat distribution, genetics, fitness, diet, medications, age, sex-related biology, and existing health conditions all contribute to overall risk.

The Short Answer: Visceral Fat Usually Carries Greater Metabolic Risk

If the question is simply which type of fat is more strongly associated with cardiometabolic disease, the answer is visceral fat.

Visceral adipose tissue is generally more strongly linked with:

• insulin resistance;
• type 2 diabetes;
• elevated triglycerides;
• lower HDL cholesterol;
• hypertension;
• fatty liver and ectopic fat accumulation;
• and cardiovascular disease risk.

Large imaging studies have repeatedly shown that visceral fat provides information about metabolic risk beyond BMI alone. In the Framingham Heart Study, for example, a greater proportion of visceral relative to subcutaneous abdominal fat was associated with multiple adverse cardiometabolic risk factors in both women and men.

But saying “visceral fat is worse” is only the starting point.

Subcutaneous and visceral adipose tissue are not merely the same cells in different locations. They differ in blood supply, inflammatory activity, hormone signaling, fatty-acid release, capacity for expansion, and how closely they communicate with organs such as the liver.

What Is Subcutaneous Fat?

Subcutaneous adipose tissue, often abbreviated SAT or SCAT, is fat stored between the skin and the underlying muscle and connective tissues.

It is distributed throughout much of the body.

Common subcutaneous fat depots include:

• the abdomen;
• hips;
• buttocks;
• thighs;
• upper arms;
• and other areas beneath the skin.

This is generally the body fat you can physically pinch between your fingers.

Subcutaneous fat is the largest adipose compartment in many adults and serves several legitimate physiological purposes.

It stores energy.

It provides insulation.

It cushions tissues.

It contributes to endocrine signaling.

And importantly, well-functioning subcutaneous adipose tissue can act as a relatively safe reservoir for storing excess fatty acids rather than allowing those lipids to accumulate in organs that are poorly suited for long-term fat storage.

What Is Visceral Fat?

Visceral adipose tissue, or VAT, is stored inside the abdominal cavity in association with internal organs.

Important visceral depots include fat within the mesentery and omentum around the intestines and other abdominal structures.

Visceral fat is therefore much deeper than ordinary abdominal subcutaneous fat.

You cannot grab visceral adipose tissue with your fingers.

It sits behind the abdominal wall.

This distinction is important because people often use “belly fat,” “abdominal fat,” and “visceral fat” as though they mean the same thing.

They do not.

The abdomen can contain substantial subcutaneous fat outside the abdominal muscles as well as visceral fat deeper inside the abdominal cavity.

A larger waist may reflect some combination of both.

Visceral Fat Is Not the Same as Fat Inside the Liver

Another common source of confusion involves ectopic fat.

Visceral fat surrounds or is associated with abdominal organs.

Ectopic fat refers to excessive lipid stored within tissues not primarily designed for large-scale fat storage, such as:

• liver;
• skeletal muscle;
• pancreas;
• or heart.

Fat accumulation inside the liver, for example, is not technically the same thing as visceral adipose tissue.

However, visceral adiposity and ectopic fat often occur together, and the metabolic processes associated with excessive visceral fat can contribute to abnormal lipid delivery and storage in organs such as the liver.

That relationship is one reason visceral obesity is so relevant to metabolic health.

Why Is Visceral Fat Considered More Harmful?

There is probably no single mechanism.

Researchers generally point to several interacting features of visceral adipose tissue.

Visceral fat releases fatty acids readily

Visceral adipocytes tend to be relatively responsive to signals that stimulate lipolysis, the process that releases fatty acids from stored triglycerides.

A high rate of fatty-acid release can increase lipid delivery to other tissues.

When fatty-acid supply exceeds what tissues can appropriately use or store, abnormal lipid accumulation can contribute to insulin resistance and metabolic dysfunction.

Some visceral fat drains toward the liver

A particularly important concept is the portal hypothesis.

Blood from several visceral abdominal fat depots drains through the portal circulation toward the liver.

That means fatty acids, glycerol, inflammatory mediators, and other substances released from visceral adipose tissue can have relatively direct access to the liver.

The liver plays a central role in controlling blood glucose, lipid production, insulin metabolism, and systemic energy regulation.

Excess portal delivery of fatty acids and inflammatory signals has therefore been proposed as one mechanism connecting visceral adiposity with liver insulin resistance, abnormal triglyceride metabolism, and broader cardiometabolic disease.

Visceral Fat Can Become Inflamed and Dysfunctional

Adipose tissue is an endocrine and immune organ, not passive storage.

As visceral adipocytes enlarge during chronic energy surplus, the tissue can undergo pathological remodeling involving:

• adipocyte enlargement;
• local hypoxia;
• immune-cell infiltration;
• inflammation;
• fibrosis;
• and adipocyte dysfunction.

A 2024 review of visceral adipose pathophysiology described these changes as major contributors to the relationship between visceral obesity and cardiometabolic disease. Dysfunctional visceral tissue can release greater amounts of fatty acids and inflammatory or profibrotic signaling molecules that affect both the liver and systemic metabolism.

This does not mean inflammation originates only in visceral fat.

Subcutaneous adipose tissue can also become inflamed and metabolically dysfunctional.

The difference is that visceral tissue tends to show a more adverse biological profile when it becomes excessive.

Is Subcutaneous Fat Harmless?

No.

This is where the simple “visceral bad, subcutaneous good” comparison breaks down.

Very large amounts of subcutaneous adipose tissue can still accompany obesity, impaired mobility, sleep apnea, inflammation, mechanical stress on joints, and other health concerns.

Abdominal subcutaneous fat is also not metabolically identical to fat stored in the thighs or hips.

Research suggests that where subcutaneous fat is located matters.

Lower-body gluteofemoral subcutaneous fat—in the hips, buttocks, and thighs—has often been associated with a more favorable metabolic profile compared with abdominal visceral fat.

So even within the broad category of subcutaneous fat, location matters.

Lower-Body Subcutaneous Fat May Act as a Metabolic Buffer

One reason lower-body subcutaneous fat may be relatively favorable is its ability to store fatty acids safely for long periods.

Adipose tissue is supposed to store fat.

Problems can arise when the body’s safer storage depots cannot expand or function effectively enough to handle continued energy surplus.

In that situation, more lipid may accumulate in visceral depots or in organs such as the liver and skeletal muscle.

Researchers sometimes describe this using the adipose tissue expandability hypothesis.

According to this model, well-functioning subcutaneous adipose tissue serves as a buffer by storing excess energy in adipocytes rather than allowing fatty acids to “spill over” into tissues where excess lipid can impair normal function.

Gluteofemoral adipose tissue may be particularly good at long-term lipid storage because its fatty acids are mobilized relatively slowly.

This is one reason having more subcutaneous fat is not automatically equivalent to having greater metabolic risk.

Abdominal Subcutaneous Fat Is More Complicated

Subcutaneous abdominal fat lies under the skin of the abdomen but outside the abdominal cavity.

It is distinct from visceral adipose tissue.

Studies generally find that abdominal subcutaneous fat is less strongly associated with cardiometabolic disease than visceral fat, although the relationship is not necessarily neutral in every population.

A review comparing abdominal depots found visceral and ectopic fat accumulation to be most consistently associated with adverse cardiometabolic outcomes, while abdominal subcutaneous fat had weaker or more neutral relationships and gluteofemoral fat tended to be associated with lower risk.

The useful conclusion is therefore not:

Subcutaneous fat is healthy.

It is:

Subcutaneous fat generally carries less cardiometabolic risk than visceral fat, and some lower-body subcutaneous depots may perform particularly useful energy-storage functions.

Subcutaneous vs. Visceral Fat at a Glance

Feature	Subcutaneous fat	Visceral fat
Location	Beneath the skin	Inside the abdominal cavity around organs
Can you pinch it?	Usually yes	No
Main role	Energy storage, insulation, cushioning, endocrine signaling	Energy storage and endocrine/immune functions within abdominal depots
Metabolic risk	Generally lower, depending on depot and amount	Generally higher when excessive
Fatty-acid release	Often slower, especially in lower-body depots	Generally more lipolytically active
Relationship with liver	Reaches systemic circulation	Some depots drain through portal circulation toward the liver
Inflammatory tendency when excessive	Can become dysfunctional	Often shows pronounced inflammatory and metabolic dysfunction
Best routine proxy	Overall body composition plus regional measurements	Waist-based measurements can provide indirect information
Precise measurement	CT or MRI can quantify regional SAT	CT or MRI can quantify VAT

Can You Tell Visceral Fat by Looking at Someone?

Not reliably.

People sometimes describe a firm, round abdomen as “visceral fat” and softer pinchable abdominal fat as “subcutaneous fat.”

There is some anatomical logic behind that distinction, but appearance and touch are not diagnostic tools.

A person’s abdominal shape is influenced by many factors, including:

• visceral adipose tissue;
• subcutaneous fat;
• muscle;
• posture;
• skeletal structure;
• abdominal-wall anatomy;
• bloating;
• organ size;
• pregnancy history;
• and genetics.

Two people with similar waist sizes can have different proportions of visceral and subcutaneous adipose tissue.

Research using imaging demonstrates substantial variation in visceral fat even among people within similar BMI categories.

Can You Have High Visceral Fat at a “Normal” BMI?

Yes.

BMI reflects weight relative to height.

It does not directly measure body-fat percentage, fat distribution, muscle mass, or visceral adipose tissue.

Someone can therefore have a BMI within the traditionally defined normal range while carrying relatively high levels of visceral or ectopic fat.

Conversely, someone with a higher BMI may carry more subcutaneous tissue and comparatively less visceral fat than another person at the same BMI.

A 2026 systematic review and meta-analysis specifically examined exercise and visceral fat in adults with normal-weight or low-overweight BMI values, reflecting growing recognition that visceral adiposity can occur even without a high BMI. The authors cautioned that evidence in this population remains limited, but the phenomenon itself is well recognized.

BMI can therefore provide useful population-level information without telling the full story about fat distribution.

Why Do Some People Store More Visceral Fat Than Others?

Body-fat distribution is influenced by a combination of:

• genetics;
• sex-related biology;
• age;
• hormonal status;
• ancestry;
• energy balance;
• physical activity;
• sleep;
• medications;
• and metabolic health.

Men, on average, tend to store a greater proportion of fat centrally and viscerally than premenopausal women, while women more commonly store a greater proportion in gluteofemoral subcutaneous depots.

After menopause, fat distribution commonly shifts toward greater central and visceral accumulation.

These are population patterns rather than rules that predict an individual person’s body composition. Genetics and ancestry also contribute to substantial variation within sexes and age groups.

For a deeper look at these distribution patterns, see our guide to why fat tends to accumulate in the belly, hips, and thighs.

Why Does Age Often Increase Visceral Fat?

Body composition commonly changes with age.

People may lose some lean mass while becoming less active, and hormonal changes can alter where adipose tissue is preferentially stored.

Older age is frequently associated with a greater proportion of abdominal and visceral fat, even when scale weight does not change dramatically.

This is another reason body weight alone can miss meaningful changes in body composition.

Someone can remain at roughly the same weight while losing muscle and accumulating more central adipose tissue.

What Role Does Genetics Play?

Body-fat distribution has a significant inherited component.

Genetic variation can influence:

• whether energy is preferentially stored centrally or peripherally;
• adipocyte development;
• fat-storage capacity;
• sex-hormone signaling;
• appetite;
• insulin sensitivity;
• and other metabolic traits.

That helps explain why some people develop relatively large abdominal visceral depots at modest overall body-fat levels, while others accumulate much more subcutaneous tissue before developing substantial visceral adiposity.

Genetics influences susceptibility.

It does not mean body-fat distribution is completely fixed.

Does Visceral Fat Cause Disease, or Is It Just a Marker?

This is an important scientific distinction.

Visceral fat is clearly associated with cardiometabolic disease.

Imaging studies consistently show relationships with insulin resistance, dyslipidemia, metabolic syndrome, coronary disease risk, and other metabolic abnormalities.

There are also plausible mechanisms by which visceral tissue itself can contribute to disease, including portal fatty-acid delivery, inflammation, altered adipokine signaling, and interactions with ectopic fat.

However, visceral fat also tends to occur alongside other metabolic abnormalities.

It can therefore function both as:

a biologically active contributor

and

a marker of a broader pattern of dysfunctional fat storage.

Scientists continue to investigate exactly how much risk is caused directly by visceral tissue versus the metabolic environment associated with having excess visceral fat.

Why the Liver Is So Important

The liver sits at the center of many metabolic processes.

It helps regulate:

• blood glucose;
• glycogen storage;
• triglyceride production;
• cholesterol metabolism;
• fatty-acid processing;
• and insulin clearance.

Because some visceral depots release products into the portal circulation, the liver can be exposed to elevated fatty-acid and inflammatory signaling.

Excessive lipid delivery can promote hepatic triglyceride accumulation and hepatic insulin resistance.

The liver may then release more glucose and triglyceride-rich lipoproteins into the bloodstream, contributing to systemic metabolic problems.

This liver connection is one of the major reasons visceral adiposity has received so much attention in metabolic research.

How Is Visceral Fat Measured?

There are several approaches, but they do not provide equivalent information.

CT scans

Computed tomography can directly visualize cross-sectional abdominal fat and distinguish visceral from subcutaneous compartments.

CT has been used extensively in research.

Its major disadvantage is exposure to ionizing radiation, which makes repeated CT scans inappropriate solely for casual body-fat tracking.

MRI

Magnetic resonance imaging can also measure visceral and subcutaneous adipose tissue and does not use ionizing radiation.

MRI is highly useful in research but is expensive and unnecessary for routine assessment in most people.

DXA

Dual-energy X-ray absorptiometry is commonly used to measure body composition and can provide estimates of regional fat, with some modern systems estimating visceral adipose tissue.

It generally provides less direct anatomical detail than CT or MRI.

Waist measurements

Waist circumference and related anthropometric measures are inexpensive, accessible ways to assess central adiposity.

They are useful clinically, but they cannot distinguish how much of the abdominal circumference comes from visceral versus subcutaneous tissue.

Current obesity guidance continues to use waist-based measures as practical tools for evaluating central adiposity and cardiometabolic risk.

Should You Get a CT or MRI to Measure Visceral Fat?

Usually not solely for this purpose.

CT and MRI can quantify visceral adipose tissue accurately, but direct imaging is generally unnecessary for routine risk assessment.

Clinicians can often obtain much of the information needed from:

• medical history;
• waist circumference;
• BMI or other body-composition measures;
• blood pressure;
• fasting glucose or HbA1c;
• blood lipids;
• liver-related markers when appropriate;
• and other cardiovascular risk factors.

Imaging may incidentally reveal visceral or ectopic fat when performed for another medical reason, or it may be used in research and selected clinical situations.

For most people, repeatedly scanning abdominal fat would add cost and complexity without necessarily changing treatment.

Is Waist Circumference a Good Measure of Visceral Fat?

It is useful, but imperfect.

Waist circumference is correlated with central adiposity and cardiometabolic risk.

It is more practical than imaging and adds information that BMI alone can miss.

However, it measures the external circumference of the abdomen.

That circumference includes both visceral and subcutaneous components.

A large waist therefore does not prove that most abdominal fat is visceral.

A smaller waist does not guarantee very low visceral fat either.

A 2024 cardiovascular review described waist circumference as a useful but imprecise measure because it cannot distinguish visceral from abdominal subcutaneous tissue.

Waist Cutoffs Are Not Universal

Waist circumference sometimes appears online as though there were one universal “healthy” threshold.

In reality, interpretation depends partly on factors such as sex and population background.

The 2026 Standards of Care in Overweight and Obesity use different waist thresholds for adults with Asian versus non-Asian backgrounds, reflecting known differences in cardiometabolic risk and body composition.

This is one reason waist measurements are most useful as part of a broader health assessment rather than as a stand-alone diagnosis.

Is a “Hard Belly” Visceral Fat?

Not necessarily.

Visceral fat can push the abdominal wall outward, which may contribute to a firmer-looking abdomen.

But abdominal firmness can also reflect muscle tension, connective tissue, posture, bloating, gastrointestinal contents, or other anatomical factors.

Touching the abdomen cannot quantify visceral adipose tissue.

If cardiometabolic risk is the concern, blood pressure, waist measures, laboratory markers, health history, and clinical assessment are more informative than whether the abdomen feels soft or firm.

Is a “Pear Shape” Healthier Than an “Apple Shape”?

These terms describe broad patterns of fat distribution.

An “apple-shaped” pattern generally refers to greater central abdominal adiposity.

A “pear-shaped” pattern refers to proportionally more fat around the hips and thighs.

Population studies generally find that greater central or visceral adiposity is associated with higher metabolic risk, while greater gluteofemoral subcutaneous fat is often associated with a more favorable metabolic profile.

But body shapes are crude categories.

They should not be used to diagnose someone’s health.

A person with more lower-body fat can still have cardiovascular risk factors, while someone who appears lean can still carry substantial visceral or ectopic fat.

Can You Have a Lot of Subcutaneous Fat but Relatively Little Visceral Fat?

Yes.

Fat distribution differs substantially among individuals.

Some people preferentially store more energy in subcutaneous depots.

From a metabolic perspective, that capacity can sometimes be advantageous because subcutaneous adipose tissue can store excess lipids away from organs.

This is one proposed explanation for the phenomenon sometimes called metabolically healthier obesity, in which certain people with a high BMI have fewer metabolic abnormalities than expected.

The term should not be interpreted to mean obesity carries no health consequences.

Metabolic status can also change over time.

But variation in fat distribution is one reason BMI alone does not perfectly predict individual cardiometabolic risk.

Can Someone Look Lean and Still Carry Visceral Fat?

Yes.

People differ in how much internal adipose tissue they store for a given external appearance.

A relatively lean-looking person can still accumulate visceral or liver fat.

This is sometimes popularly described as being “thin outside, fat inside,” although the phrase is informal rather than a formal diagnosis.

Factors such as genetics, low muscle mass, aging, inactivity, and metabolic susceptibility may contribute.

Again, appearance alone is a poor substitute for measuring actual health markers.

Blood pressure, blood glucose, blood lipids, activity level, fitness, waist measurements, smoking status, and family history may provide far more useful information.

Can Visceral Fat Be Reduced?

Yes.

Visceral adipose tissue is metabolically responsive and can decrease with sustained lifestyle or medical interventions that reduce adiposity.

Calorie restriction and weight loss generally reduce both visceral and subcutaneous fat.

Exercise can also reduce visceral fat, including in some studies without large changes in body weight.

A 2024 network meta-analysis of 84 randomized trials found reductions in visceral adipose tissue with aerobic exercise, resistance training, combined training, and high-intensity interval training in adults with overweight or obesity.

The important point is that visceral fat is not permanently trapped around the organs.

Our guide to how to reduce visceral fat around the organs examines the practical evidence in detail.

Do You Lose Visceral Fat Faster Than Subcutaneous Fat?

It depends on how the comparison is made.

Visceral depots are usually smaller in absolute mass than subcutaneous depots.

Research has found that the percentage reduction in visceral fat can sometimes be greater than the percentage reduction in subcutaneous fat during weight loss, even though the absolute amount of subcutaneous fat lost may be larger.

That distinction prevents a common misunderstanding.

Suppose someone loses:

• 20% of a small visceral depot;
• and 12% of a much larger subcutaneous depot.

The visceral percentage reduction is greater, yet more total kilograms of subcutaneous fat could still have been lost.

Both tissues generally decrease when total adiposity decreases.

Can Exercise Reduce Visceral Fat Without Major Weight Loss?

Yes, to some extent.

Exercise studies have documented reductions in visceral adipose tissue even when scale-weight changes are relatively modest.

A systematic review comparing calorie restriction and structured exercise found that both approaches can reduce abdominal visceral and subcutaneous fat, although the patterns of change differed across interventions.

This is one reason the scale does not capture every benefit of exercise.

Improved fitness, blood pressure, insulin sensitivity, muscle mass, and regional fat distribution can all change without dramatic total-weight loss.

Can You Specifically Spot-Reduce Visceral Fat?

There is no exercise that makes only visceral adipocytes release fat while leaving other depots untouched.

Visceral fat often responds well to overall energy imbalance and exercise, but that is different from consciously targeting a specific depot.

Sit-ups, abdominal machines, and core exercises can strengthen the muscles of the trunk.

They do not mechanically burn the visceral tissue lying behind those muscles.

Body-fat distribution and regional responsiveness are controlled by systemic physiology, not by which muscle happens to be contracting nearby.

Is Visceral Fat More Dangerous Than Total Body Fat?

The most accurate answer is that both amount and distribution matter.

Visceral fat provides additional information about cardiometabolic risk.

But a person should not ignore total adiposity simply because visceral fat is considered more metabolically active.

Likewise, BMI should not be the only measure considered when fat distribution and health markers suggest a different risk profile.

The most useful assessment combines several pieces of information:

• overall adiposity;
• central adiposity;
• blood pressure;
• glucose regulation;
• lipid profile;
• smoking;
• fitness;
• family history;
• medical conditions;
• and other risk factors.

Visceral fat is one important part of that picture.

It is not the entire picture.

Common Myths About Visceral and Subcutaneous Fat

Myth	More accurate explanation
“All belly fat is visceral fat.”	Abdominal fat includes both subcutaneous fat beneath the skin and visceral fat deeper inside the abdomen.
“If I can pinch it, it is dangerous visceral fat.”	Pinchable fat is primarily subcutaneous tissue.
“Subcutaneous fat is harmless.”	Its metabolic risk is generally lower, but excessive or dysfunctional subcutaneous adiposity can still matter.
“Visceral fat means fat inside the liver.”	Visceral adipose tissue and liver fat are different, although they frequently occur together.
“A normal BMI means visceral fat is low.”	BMI does not directly measure visceral fat or fat distribution.
“You can diagnose visceral fat from body shape.”	Appearance provides only rough clues; imaging is needed for precise measurement.
“Ab exercises burn visceral belly fat.”	Core exercises strengthen abdominal muscles but do not selectively remove visceral fat.

Which Type Should You Be More Concerned About?

From a cardiometabolic perspective, excessive visceral adipose tissue deserves particular attention.

But the practical goal should not be to become preoccupied with measuring one hidden fat compartment.

If someone has:

• a high or increasing waist circumference;
• elevated blood pressure;
• abnormal cholesterol or triglycerides;
• prediabetes or diabetes;
• fatty liver disease;
• a strong family history of cardiometabolic disease;
• or other relevant risk factors,

a healthcare professional can assess the broader metabolic picture.

The appropriate response usually focuses on improving overall health through nutrition, physical activity, sleep, smoking cessation when relevant, appropriate weight management, and treatment of conditions such as hypertension, diabetes, dyslipidemia, or obesity.

Visceral fat is clinically important largely because it helps us understand risk, not because everyone needs to know the exact volume of fat surrounding their organs.

The Bottom Line

Subcutaneous and visceral fat are both adipose tissue, but location changes their biological significance.

Subcutaneous fat lies beneath the skin and represents a major energy-storage compartment. Some subcutaneous depots—particularly around the hips and thighs—may provide relatively safe long-term lipid storage and are often associated with a more favorable metabolic profile.

Visceral fat lies deeper inside the abdomen. When excessive, it is more strongly associated with insulin resistance, abnormal blood lipids, type 2 diabetes, fatty liver, hypertension, and cardiovascular disease.

Its higher risk appears to reflect several factors, including greater fatty-acid release, inflammatory activity, tissue dysfunction, and direct communication between some visceral depots and the liver through the portal circulation.

But visceral fat should not become another isolated number to chase.

BMI, waist circumference, total body fat, fat distribution, fitness, laboratory results, blood pressure, genetics, and medical history all provide different pieces of the health picture.

The most useful takeaway is therefore simple:

Where fat is stored matters—but overall metabolic health matters more than any single fat depot viewed in isolation.

References

1. Lee M-J, Kim J. “The Pathophysiology of Visceral Adipose Tissues in Cardiometabolic Diseases.” Biochemical Pharmacology, 2024;222:116116. Review of visceral-fat remodeling, portal fatty-acid delivery, inflammation, insulin resistance, and cardiometabolic disease mechanisms.
2. Kaess BM, Pedley A, Massaro JM, Murabito J, Hoffmann U, Fox CS. “The Ratio of Visceral to Subcutaneous Fat, a Metric of Body Fat Distribution, Is a Unique Correlate of Cardiometabolic Risk.” Diabetologia, 2012;55(10):2622–2630. Framingham Heart Study analysis using CT-measured visceral and subcutaneous abdominal fat.
3. Alser M, Naja K, Elrayess MA. “Mechanisms of Body Fat Distribution and Gluteal-Femoral Fat Protection Against Metabolic Disorders.” Frontiers in Nutrition, 2024;11:1368966. Review of regional fat distribution and potential protective functions of gluteofemoral subcutaneous adipose tissue.
4. Yi D, Tang X, Xing Z. “Visceral and Subcutaneous Adiposity and Cardiovascular Disease: Unravelling Associations and Prognostic Value.” Diabetes, Obesity and Metabolism, 2024;26(12):5819–5826. Review comparing visceral fat, abdominal subcutaneous fat, waist circumference, and cardiovascular risk.
5. Bennett JP, Prado CM, Heymsfield SB, Shepherd JA. “Evaluation of Visceral Adipose Tissue Thresholds for Elevated Metabolic Syndrome Risk Across Diverse Populations: A Systematic Review.” Obesity Reviews, 2024;25(9):e13767. Systematic review demonstrating population and measurement variability in visceral-fat risk thresholds.
6. “Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults: Standards of Care in Overweight and Obesity—2026.” 2026. Contemporary clinical guidance addressing central adiposity, waist measurement, BMI limitations, and body-composition assessment.